Stockscreener 앱 받기
1.21
4.72%
-0.06
전일 마감가:
$1.27
열려 있는:
$1.26
하루 거래량:
4.19M
Relative Volume:
1.59
시가총액:
$23.78M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.1825
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
+42.35%
1개월 성능:
+46.35%
6개월 성능:
+42.86%
1년 성능:
-56.79%
1일 변동 폭
$1.14
$1.27
1주일 범위
$0.8642
$1.72
52주 변동 폭
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
IBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.21 | 25.72M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Oppenheimer | Outperform |
| 2025-10-17 | 개시 | Leerink Partners | Outperform |
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
모두보기
iBio Inc 주식(IBIO)의 최신 뉴스
How buybacks impact iBio Inc. stock valueQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Why iBio Inc. (0JV0) stock could be next leaderMarket Performance Report & Weekly Return Optimization Plans - newser.com
Risk vs reward if holding onto iBio Inc.2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
Why iBio Inc. stock is rated strong buyMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Analyzing iBio Inc. with multi timeframe chartsMarket Sentiment Report & Technical Pattern Alert System - newser.com
Real time pattern detection on iBio Inc. stock2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
iBio (IBIO) Gains Attention with Promising Obesity Treatment - GuruFocus
Biotech Alert: Searches spiking for these stocks today - TipRanks
Does iBio Inc. (0JV0) stock trade below intrinsic value2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
iBio (IBIO) Gains Positive Outlook with Analyst Coverage and Inn - GuruFocus
Is IBIO Stock On The Verge Of A Breakthrough? - StocksToTrade
iBio Surges: Big Moves on the Horizon? - timothysykes.com
Is iBio Inc. stock attractive for long term wealth building2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim - Stock Titan
Why Did iBio Shares Surge Over 11% In Pre-Market Trading? - Benzinga
IBIO insider Form 4: CFO awarded 75,000 options, vesting over 3 years - Stock Titan
Form 4: iBio awards 55,000 options to Chief Legal Officer - Stock Titan
What analysts say about iBio Inc 0JV0 stockGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in
iBio (IBIO) Gains Attention with Innovative Drug Development - GuruFocus
Ibio Inc. sell Wolf_of_WS - sharewise.com
iBio initiated with an Outperform at Oppenheimer - MSN
Key resistance and support levels for iBio Inc.July 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
iBio Inc. stock retracement – recovery analysisMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com
IBIO Stocks Skyrocket: An In-Depth Overview - StocksToTrade
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Oppenheimer Initiates Coverage of iBio (IBIO) with Outperform Recommendation - Nasdaq
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs - ts2.tech
Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target - MarketScreener
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - The Manila Times
Oppenheimer Initiates Coverage on IBIO with an Outperform Rating - GuruFocus
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Is iBio Inc. (0JV0) stock worth holding before Fed meetingGap Down & Weekly Watchlist for Hot Stocks - newser.com
Oppenheimer initiates iBio stock with Outperform rating on obesity drug potential - Investing.com Canada
What analysts say about iBio Inc stockMarket Insider Reports & Grow Steadily With Our Wealth Roadmap - earlytimes.in
How to manage a losing position in iBio Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com
Tick level data insight on iBio Inc. volatility2025 Institutional Moves & Detailed Earnings Play Strategies - newser.com
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.29%
자본화:
|
볼륨(24시간):